GRN163L
Showing 1 - 25 of 4,630
Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)
Completed
- Primary Myelofibrosis
- +2 more
-
Rochester, Minnesota(unnamed)
Aug 24, 2021
MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)
Not yet recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
-
Adelaide, Australia
- +11 more
Oct 13, 2022
Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))
Recruiting
- Myelofibrosis
- Imetelstat
- Best Available Therapy (BAT)
-
La Jolla, California
- +165 more
Aug 19, 2022
Periodontitis Trial in Poltava (Scaling and root planing, Oral L-arginine aspartate administration, Oral L-ornithine aspartate
Completed
- Periodontitis
- Scaling and root planing
- +2 more
-
Poltava, UkraineUkrainian Medical Stomatological Academy
Sep 11, 2021
Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer Trial (Imetelstat Sodium,
Withdrawn
- Hepatoblastoma
- +7 more
- Imetelstat Sodium
- Laboratory Biomarker Analysis
- (no location specified)
Aug 3, 2018
Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II Trial in United States (imetelstat sodium)
Terminated
- Anaplastic Astrocytoma
- +8 more
- imetelstat sodium
-
Los Angeles, California
- +10 more
Jun 20, 2018
Alzheimer Trial in Worldwide (LY3372689, Placebo)
Active, not recruiting
- Alzheimer Disease
- LY3372689
- Placebo
-
Canoga Park, California
- +70 more
Jan 18, 2023
Generalized Anxiety Disorder Trial in Worldwide (Pregabalin, Placebo)
Completed
- Generalized Anxiety Disorder
- Pregabalin
- Placebo
-
San Pedro De Montes De Oca, San José, Costa Rica
- +20 more
Jan 21, 2021
Critical Illness Trial in Mansoura (Lactoferrin)
Not yet recruiting
- Critical Illness
-
Mansoura, El-dakhlia, EgyptMansoura University hospital
Jul 6, 2023
Hypoactive Sexual Desire Disorder Trial in Canada, United States (testosterone gel, gel)
Completed
- Hypoactive Sexual Desire Disorder
- testosterone gel
- placebo gel
-
Birmingham, Alabama
- +148 more
Oct 27, 2021
Chronic Cluster Headache Trial in Worldwide (Fremanezumab, Placebo)
Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)
Completed
- Myelofibrosis
- Imetelstat 4.7 mg/kg
- Imetelstat 9.4 mg/kg
-
Birmingham, Alabama
- +71 more
Aug 17, 2021
Tumour Trial in Hangzhou (Mirabegron)
Recruiting
- Tumour
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Mar 9, 2023
HBV Infection, Chronic Hepatitis b Trial in China (Tenofovir Amibufenamide(TMF))
Recruiting
- HBV Infection
- Chronic Hepatitis b
- Tenofovir Amibufenamide(TMF)
-
Beijing, China
- +11 more
Mar 22, 2023
Acute Ischemic Stroke Trial in China (Alteplase, Tenecteplase)
Recruiting
- Acute Ischemic Stroke
-
Xuancheng, Anhui, China
- +62 more
Feb 16, 2023
Bowel Cleansing; Good Taste Trial in Ningbo (Mannitol, Polyethylene glycol electrolyte)
Recruiting
- Bowel Cleansing; Good Taste
- Mannitol
- Polyethylene glycol electrolyte
-
Ningbo, Zhejiang, ChinaNingbo first hospital
Jun 12, 2023
Non-small-cell Lung Cancer Trial in China (TQB2450 +Anlotinib+Docetaxel, TQB2450 +Androtinib Placebo+Docetaxel)
Recruiting
- Non-small-cell Lung Cancer
- TQB2450 +Anlotinib+Docetaxel
- TQB2450 +Androtinib Placebo+Docetaxel
-
Huizhou, Guangdong, China
- +4 more
Nov 15, 2023
A Real-World Patient-Reported Outcomes Study in Long-Term Use of
Recruiting
- Ovarian Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 13, 2023
Mild Cognitive Impairment(MCI), Alzheimer, Late Onset, Familial Alzheimer (FAD) Trial in China
Recruiting
- Mild Cognitive Impairment(MCI)
- +5 more
-
Hefei, Anhui, China
- +64 more
Jan 2, 2023
Non Small Cell Lung Cancer Trial in China (TQB2450 injection + Chemotherapy, TQB2450 injection + Anlotinib Hydrochloride
Recruiting
- Non Small Cell Lung Cancer
- TQB2450 injection + Chemotherapy
- TQB2450 injection + Anlotinib Hydrochloride Capsule
-
Beijing, Beijing, China
- +9 more
Jun 27, 2023
Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte
Recruiting
- Acute Myeloid Leukemia
- Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
- "3+7"
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Sep 29, 2023
NSCLC Trial in Shanghai (Toripalimab, Cryoablation)
Not yet recruiting
- Non-small Cell Lung Cancer
- Toripalimab
- Cryoablation
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 7, 2023